ConductScience.org, home

Paper41892432

Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.

Miftode IL and 9 others. Antibiotics (Basel), 2026. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions. Papers, record 41892432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41892432

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
3.64, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miftode ILIonela-Larisahttps://orcid.org/0000-0003-4131-1019
2Radu VDViorel Dragoșhttps://orcid.org/0009-0008-2065-2926
3Jigoranu RARaul-Alexandru
4Leca DADaniela-Anicuța
5Prepeliuc CSCristian Sorin
6Pasare MAMaria Antoanelahttps://orcid.org/0000-0002-9420-5386
7Miftode RSRadu-Stefanhttps://orcid.org/0000-0002-2610-6482
8Grigoriu MGMaria Gabriela
9Parângă TGTudorița Gabrielahttps://orcid.org/0000-0002-8404-2771
10Miftode EGEgidia Gabrielahttps://orcid.org/0000-0002-8644-095X

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
141,009,897Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance.Antibiotics (Basel)2025https://conductscience.org/library/papers/41009897PubMed
240,503,958Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas-derived cephalosporinase variant PDC-88.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40503958PubMed
339,144,447Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.JAC Antimicrob Resist2024https://conductscience.org/library/papers/39144447PubMed
437,566,365Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland.Eur J Clin Microbiol Infect Dis2023https://conductscience.org/library/papers/37566365PubMed
539,978,636Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia: a 5-year cohort study in intensive care patients.Clin Microbiol Infect2025https://conductscience.org/library/papers/39978636PubMed
639,162,506RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species.Microbiol Spectr2024https://conductscience.org/library/papers/39162506PubMed
740,555,322Metagenomic and whole-genome characterization of carbapenem-resistant Acinetobacter baumannii carrying blaOXA-23 gene within the Tn2006 transposon among ICU patients.J Glob Antimicrob Resist2025https://conductscience.org/library/papers/40555322PubMed
838,402,870Whole Genome Sequencing: Applications in Clinical Bacteriology.Med Princ Pract2024https://conductscience.org/library/papers/38402870PubMed
937,901,589Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae.JAC Antimicrob Resist2023https://conductscience.org/library/papers/37901589PubMed
1038,078,718False-positive imipenemase detected by NG-Test CARBA-5 in carbapenem-resistant Acinetobacter baumannii.Microbiol Spectr2024https://conductscience.org/library/papers/38078718PubMed
1133,069,233Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae.BMC Microbiol2020https://conductscience.org/library/papers/33069233PubMed
1238,406,830Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022.Emerg Microbes Infect2024https://conductscience.org/library/papers/38406830PubMed
1337,125,466Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.Clin Infect Dis2023https://conductscience.org/library/papers/37125466PubMed
1439,672,348In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China.Int J Antimicrob Agents2025https://conductscience.org/library/papers/39672348PubMed
1537,623,430Molecular characterization and comparison of bla NDM-1-carrying and bla NDM-5-harboring IncX3-type plasmids in carbapenem-resistant Klebsiella pneumoniae.Microbiol Spectr2023https://conductscience.org/library/papers/37623430PubMed
1638,506,533Outbreak of NDM-5-producing Klebsiella pneumoniae ST307: an emerging high-risk antimicrobial resistance clone in Shanghai, China.mSystems2024https://conductscience.org/library/papers/38506533PubMed
1739,210,044Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria.Commun Med (Lond)2024https://conductscience.org/library/papers/39210044PubMed
1840,240,992Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa.BMC Microbiol2025https://conductscience.org/library/papers/40240992PubMed
1937,325,251Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization.JAC Antimicrob Resist2023https://conductscience.org/library/papers/37325251PubMed
2040,310,344Assessment of Phenotypic Tools for Detection of OXA-48, KPC, and NDM in Klebsiella pneumoniae in Oman.Diagnostics (Basel)2025https://conductscience.org/library/papers/40310344PubMed

See all 179 references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42,989,078Clinical infection and molecular characteristics of carbapenem-resistant organisms among children in China, 2016-2025.BMC Microbiol2026https://conductscience.org/library/papers/42989078PubMed
42,938,701Whole-Genome Analysis of Genomic Diversity and Antimicrobial Resistance Among Clinical Klebsiella pneumoniae Isolates from Farwaniya Hospital in Kuwait.Antibiotics (Basel)2026https://conductscience.org/library/papers/42938701PubMed
42,798,984Glutamate Potentiates Meropenem Killing of Carbapenem-Resistant Pseudomonas aeruginosa by Increasing Outer Membrane Permeability to Increase Uptake.ACS Omega2026https://conductscience.org/library/papers/42798984PubMed
42,792,035Rising Carbapenem MICs and Clinical Dose Optimization: Bridging Resistance Surveillance and Pharmacokinetic/Pharmacodynamic Strategies.Antibiotics (Basel)2026https://conductscience.org/library/papers/42792035PubMed
42,357,333Pre-Target Interception Defines Carbapenem Failure in Carbapenem-Resistant Enterobacterales: A Mechanistic Framework for Spatiotemporal Drug Reprogramming.Pharmaceutics2026https://conductscience.org/library/papers/42357333PubMed
42,353,110Phylogenetic Relationships and Structural Conservation of blaOXA-48-like Carbapenemase in Multispecies Clinical Strains from an Intensive Care Unit in Pakistan.Int J Mol Sci2026https://conductscience.org/library/papers/42353110PubMed
42,248,958Whole-genome sequencing reveals high-risk ESBL and carbapenemase-producing Enterobacterales on maternity ward surfaces in Cameroon.Sci Rep2026https://conductscience.org/library/papers/42248958PubMed
42,240,081
Duplex Recombinase Polymerase Amplification-Lateral Flow Assay for Rapid Visual Detection of Critical Antibiotic Resistance Genes in Escherichia coli and Klebsiella pneumoniae From Positive Blood Cultures.
J Clin Lab Anal2026https://conductscience.org/library/papers/42240081PubMed
42,197,440KPC-2 Orchestrates Systemic Metabolic Rewiring to Facilitate Antibiotic Adaptation in Klebsiella pneumoniae.Microorganisms2026https://conductscience.org/library/papers/42197440PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNRPE6,635PubTator's text mininghttps://conductscience.org/library/genes/6635

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41892432

GET https://conductscience.org/api/papers/v1/41892432/references?page=2